153 related articles for article (PubMed ID: 23455497)
1. Host b7x promotes pulmonary metastasis of breast cancer.
Abadi YM; Jeon H; Ohaegbulam KC; Scandiuzzi L; Ghosh K; Hofmeyer KA; Lee JS; Ray A; Gravekamp C; Zang X
J Immunol; 2013 Apr; 190(7):3806-14. PubMed ID: 23455497
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
3. A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression.
Liu Y; John P; Nishitani K; Cui J; Nishimura CD; Christin JR; Couturier N; Ren X; Wei Y; Pulanco MC; Galbo PM; Zhang X; Fu W; Cui W; Bartholdy BA; Zheng D; Lauvau G; Fineberg SA; Oktay MH; Zang X; Guo W
Dev Cell; 2023 Dec; 58(23):2700-2717.e12. PubMed ID: 37963469
[TBL] [Abstract][Full Text] [Related]
4. Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma.
Podojil JR; Glaser AP; Baker D; Courtois ET; Fantini D; Yu Y; Eaton V; Sivajothi S; Chiang M; Das A; McLaughlin KA; Robson P; Miller SD; Meeks JJ
Oncoimmunology; 2020; 9(1):1744897. PubMed ID: 32363111
[TBL] [Abstract][Full Text] [Related]
5. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.
Coffelt SB; Kersten K; Doornebal CW; Weiden J; Vrijland K; Hau CS; Verstegen NJM; Ciampricotti M; Hawinkels LJAC; Jonkers J; de Visser KE
Nature; 2015 Jun; 522(7556):345-348. PubMed ID: 25822788
[TBL] [Abstract][Full Text] [Related]
6. The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy.
John P; Pulanco MC; Galbo PM; Wei Y; Ohaegbulam KC; Zheng D; Zang X
Nat Commun; 2022 May; 13(1):2506. PubMed ID: 35523809
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic, clinicopathological features and prognostic value of B7x expression in Chinese women with breast cancer: A meta-analysis.
Su H; Lin X; Huo J; Zhang F
Asian J Surg; 2023 Nov; 46(11):5210-5216. PubMed ID: 37481357
[No Abstract] [Full Text] [Related]
8. Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?
Bakács T; Mehrishi JN
BMC Cancer; 2010 Jun; 10():251. PubMed ID: 20525172
[TBL] [Abstract][Full Text] [Related]
9. Structure and cancer immunotherapy of the B7 family member B7x.
Jeon H; Vigdorovich V; Garrett-Thomson SC; Janakiram M; Ramagopal UA; Abadi YM; Lee JS; Scandiuzzi L; Ohaegbulam KC; Chinai JM; Zhao R; Yao Y; Mao Y; Sparano JA; Almo SC; Zang X
Cell Rep; 2014 Nov; 9(3):1089-98. PubMed ID: 25437562
[TBL] [Abstract][Full Text] [Related]
10. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
[TBL] [Abstract][Full Text] [Related]
12. B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis.
Pawar RD; Goilav B; Xia Y; Herlitz L; Doerner J; Chalmers S; Ghosh K; Zang X; Putterman C
Clin Exp Immunol; 2015 Feb; 179(2):329-43. PubMed ID: 25205493
[TBL] [Abstract][Full Text] [Related]
13. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
14. An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer.
Leong SR; Liang WC; Wu Y; Crocker L; Cheng E; Sampath D; Ohri R; Raab H; Hass PE; Pham T; Firestein R; Li D; Schutten M; Stagg NJ; Ogasawara A; Koppada N; Roth L; Williams SP; Lee BC; Chalouni C; Peng I; DeVoss J; Tremayne J; Polakis P; Polson AG
Mol Pharm; 2015 Jun; 12(6):1717-29. PubMed ID: 25853436
[TBL] [Abstract][Full Text] [Related]
15. The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy.
Leung J; Suh WK
Immune Netw; 2014 Dec; 14(6):265-76. PubMed ID: 25550693
[TBL] [Abstract][Full Text] [Related]
16. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
Shi H; Ji M; Wu J; Zhou Q; Li X; Li Z; Zheng X; Xu B; Zhao W; Wu C; Jiang J
World J Surg Oncol; 2014 Jun; 12():188. PubMed ID: 24947047
[TBL] [Abstract][Full Text] [Related]
17. B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms.
Liu WH; Chen YY; Zhu SX; Li YN; Xu YP; Wu XJ; Guo YH; Wang JL
Oncol Lett; 2014 Dec; 8(6):2527-2534. PubMed ID: 25364421
[TBL] [Abstract][Full Text] [Related]
18. The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer.
Chen Y; Sun J; Zhao H; Zhu D; Zhi Q; Song S; Zhang L; He S; Kuang Y; Zhang Z; Li D
Onco Targets Ther; 2014; 7():1465-72. PubMed ID: 25170273
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of monoclonal antibody against human B7-H4 molecule.
Zhang N; Fang P; Gu ZJ
Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):270-4. PubMed ID: 25171007
[TBL] [Abstract][Full Text] [Related]
20. B7x and myeloid-derived suppressor cells in the tumor microenvironment: A tale of two cities.
Jeon H; Ohaegbulam KC; Abadi YM; Zang X
Oncoimmunology; 2013 Jul; 2(7):e24744. PubMed ID: 24073367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
